AQR Capital Management
ALDX icon

AQR Capital Management’s Aldeyra Therapeutics ALDX Stock Holding History

AQR Capital Management’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.78M Buy
2,829,875
+1,602,953
+131% +$7.02M ﹤0.01% 1785
2025
Q4 		$6.36M Sell
1,226,922
-278,438
-18% -$1.43M ﹤0.01% 1433
2025
Q3 		$7.86M Buy
1,505,360
+31,548
+2% +$165K 0.01% 1206
2025
Q2 		$5.64M Buy
1,473,812
+1,081,257
+275% +$2.8M ﹤0.01% 1216
2025
Q1 		$2.26M Buy
392,555
+321,992
+456% +$1.9M ﹤0.01% 1540
2024
Q4 		$352K Buy
+70,563
New +$362K ﹤0.01% 2428
2024
Q3 		– Sell
-34,781
Closed -$115K – 2756
2024
Q2 		$115K Sell
34,781
-70,273
-67% -$275K ﹤0.01% 2485
2024
Q1 		$344K Buy
+105,054
New +$346K ﹤0.01% 2093
2023
Q4 		– Sell
-20,913
Closed -$140K – 2327
2023
Q3 		$140K Sell
20,913
-5,245
-20% -$38.9K ﹤0.01% 2188
2023
Q2 		$219K Buy
+26,158
New +$258K ﹤0.01% 2060
2022
Q3 		– Sell
-40,954
Closed -$163K – 2178
2022
Q2 		$163K Buy
+40,954
New +$141K ﹤0.01% 2018
2021
Q3 		– Sell
-22,629
Closed -$256K – 2238
2021
Q2 		$256K Buy
+22,629
New +$272K ﹤0.01% 2086
2019
Q2 		– Sell
-20,145
Closed -$182K – 2061
2019
Q1 		$182K Buy
20,145
+7,171
+55% +$60.9K ﹤0.01% 2088
2018
Q4 		$108K Buy
+12,974
New +$133K ﹤0.01% 2144

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

AQR Capital Management's ALDX Position: Q1 2026 in Review

AQR Capital Management increased its Aldeyra Therapeutics (ALDX) stake by 131% in Q1 2026, buying an estimated $7.02M and bringing the position to 2,829,875 shares worth $4.78M. The position accounts for ﹤0.01% of the portfolio, ranked #1785.

AQR Capital Management first reported a position in ALDX in Q4 2018 and has held it in 14 quarters since. The position peaked at $7.86M in Q3 2025. 126 funds tracked by Wall St. Rank hold ALDX as of Q1 2026.

  • AQR Capital Management held 2,829,875 shares of Aldeyra Therapeutics worth $4.78M as of Q1 2026.
  • AQR Capital Management bought 1,602,953 Aldeyra Therapeutics shares in Q1 2026, an estimated $7.02M.
  • Aldeyra Therapeutics made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #1785 holding.
  • AQR Capital Management first reported a position in Aldeyra Therapeutics in Q4 2018 and has held it in 14 quarters since.
  • AQR Capital Management's Aldeyra Therapeutics position peaked at $7.86M in Q3 2025.
  • 126 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.